Trials / Unknown
UnknownNCT01554787
Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Astragalus Membranaceus in the Patients After Stroke With Fatigue
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- China Medical University Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The high levels of fatigue in stroke patients without neurological impairment suggest it has a central origin rather than being the result of increased physical effort required after stroke(Winward et al., 2009). Fatigue is different from post-stroke depression and the more serious stroke patients are more prone to fatigue(Windward et al., 2009). Fatigue is one of the symptoms of qi deficiency,and Astragalus membranaceus is the most effective of all traditional Chinese medicine and can tonifying middle and tonify the original qi. Therefore, the aim of this study was to investigate the efficacy of Astragalus membranaceus on post-stroke fatigue.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chinese Herb Astragalus membranaceus | Astragalus membranaceus(AM)at a rate of 2.8g three times per day |
| OTHER | Placebo | at a rate of 2.8g three times per day |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-12-01
- First posted
- 2012-03-15
- Last updated
- 2012-03-15
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01554787. Inclusion in this directory is not an endorsement.